WPA
CTSO icon

Winning Points Advisors’s Cytosorbents Corp CTSO Stock Holding History

Winning Points Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-22,900
Closed -$33K – 46
2022
Q3 		$33K Sell
22,900
-2,000
-8% -$3.91K 0.04% 47
2022
Q2 		$54K Sell
24,900
-43,500
-64% -$99.9K 0.06% 52
2022
Q1 		$218K Buy
+68,400
New +$245K 0.17% 53
2021
Q4 		– Sell
-86,200
Closed -$701K – 72
2021
Q3 		$701K Sell
86,200
-50,700
-37% -$412K 0.51% 39
2021
Q2 		$1.03M Sell
136,900
-2,200
-2% -$18.5K 0.78% 30
2021
Q1 		$1.2M Hold
139,100
– – 0.9% 29
2020
Q4 		$1.11M Sell
139,100
-4,000
-3% -$33.5K 0.89% 28
2020
Q3 		$1.14M Buy
143,100
+86,600
+153% +$781K 0.97% 26
2020
Q2 		$559K Buy
56,500
+21,500
+61% +$197K 0.53% 35
2020
Q1 		$269K Buy
35,000
+5,000
+17% +$25.2K 0.26% 47
2019
Q4 		$115K Buy
+30,000
New +$131K 0.07% 74

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Winning Points Advisors's CTSO Position: Q4 2022 in Review

Winning Points Advisors sold out of Cytosorbents Corp (CTSO) in Q4 2022, closing a stake of 22,900 shares — an estimated $33K sold.

Winning Points Advisors first reported a position in CTSO in Q4 2019 and held it in 11 quarters. The position peaked at $1.2M in Q1 2021. 53 funds tracked by Wall St. Rank hold CTSO as of Q4 2022.

  • Winning Points Advisors reported no remaining Cytosorbents Corp position as of Q4 2022 after selling out during the quarter.
  • Winning Points Advisors sold 22,900 Cytosorbents Corp shares in Q4 2022, an estimated $33K.
  • Winning Points Advisors first reported a position in Cytosorbents Corp in Q4 2019 and held it in 11 quarters.
  • Winning Points Advisors's Cytosorbents Corp position peaked at $1.2M in Q1 2021.
  • 53 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2022.

Based on Winning Points Advisors's 13F filing for Q4 2022, filed 10 Feb 2023.